WestEnd Advisors’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.24K Hold
53
– – ﹤0.01% 139
2026
Q2
$4.81K Buy
53
+6
+13% +$548 ﹤0.01% 119
2026
Q1
$4.82K Hold
47
– – ﹤0.01% 104
2025
Q4
$5.89K Sell
47
-6
-11% -$764 ﹤0.01% 97
2025
Q3
$7.1K Sell
53
-22
-29% -$2.89K ﹤0.01% 85
2025
Q2
$10.2K Buy
75
+8
+12% +$1.06K ﹤0.01% 77
2025
Q1
$8.89K Buy
67
+44
+191% +$5.6K ﹤0.01% 78
2024
Q4
$2.6K Buy
23
+3
+15% +$347 ﹤0.01% 95
2024
Q3
$2.28K Sell
20
-2
-9% -$219 ﹤0.01% 88
2024
Q2
$2.29K Sell
22
-6
-21% -$636 ﹤0.01% 83
2024
Q1
$3.18K Buy
28
+1
+4% +$115 ﹤0.01% 71
2023
Q4
$2.97K Buy
27
+3
+13% +$300 ﹤0.01% 77
2023
Q3
$2.32K Buy
+24
New +$2.52K ﹤0.01% 79
2023
Q1
– Sell
-20
Closed -$2.11K – 77
2022
Q4
$2.2K Sell
20
-3
-13% -$311 ﹤0.01% 74
2022
Q3
$2K Buy
23
+1
+5% +$107 ﹤0.01% 80
2022
Q2
$2.39K Buy
+22
New +$2.5K ﹤0.01% 82
2022
Q1
– Sell
-13
Closed -$1.61K – 80
2021
Q4
$1.83K Buy
+13
New +$1.66K ﹤0.01% 81
2021
Q3
– Hold
0
– – – 80
2021
Q2
– Hold
0
– – – 75
2013
Q3
– Sell
-270
Closed -$9.42K – 36
2013
Q2
$9.42K Buy
+270
New +$9.9K ﹤0.01% 39

Other funds holding ABT

WestEnd Advisors's ABT Position: Q3 2026 in Review

WestEnd Advisors held its Abbott (ABT) position steady in Q3 2026 at 53 shares worth $5.24K. The position accounts for ﹤0.01% of the portfolio, ranked #139.

WestEnd Advisors first reported a position in ABT in Q2 2013 and has held it in 18 quarters since. The position peaked at $10.2K in Q2 2025. 1,254 funds tracked by Wall St. Rank hold ABT as of Q3 2026.

  • WestEnd Advisors held 53 shares of Abbott worth $5.24K as of Q3 2026.
  • WestEnd Advisors left its Abbott share count unchanged in Q3 2026.
  • Abbott made up ﹤0.01% of WestEnd Advisors's portfolio in Q3 2026, its #139 holding.
  • WestEnd Advisors first reported a position in Abbott in Q2 2013 and has held it in 18 quarters since.
  • WestEnd Advisors's Abbott position peaked at $10.2K in Q2 2025.
  • 1,254 funds tracked by Wall St. Rank held Abbott as of Q3 2026.

Based on WestEnd Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.